Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stentrode With Thought-controlled Digital Switch: An Early Feasibility Study (EFS) of the Safety of the Stentrode Device in Participants With Loss of Motor Function Due to Paralysis

NCT03834857 is registered in ClinicalTrials.gov with Synchron Australia Pty Ltd. as lead sponsor.

NCT NCT03834857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03834857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stentrode With Thought-controlled Digital Switch: An Early Feasibility Study (EFS) of the Safety of the Stentrode Device in Participants With Loss of Motor Function Due to Paralysis
Lead sponsor
Synchron Australia Pty Ltd.
Phase
Not applicable
Overall status
Completed
Start date
May 27, 2019
Completion date
January 9, 2022
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurologic disorder